Glycomed
Executive Summary
Privately-held carbohydrate pharmaceutical R&D firm, based in Alameda, California, completes two private placements totaling$15.5 mil. The fundings include a $4 mil. equity investment by Lilly that is part of a three-year research agreement announced in January ("The Pink Sheet" Jan. 15, In Brief).